KIMBERLY MIDDLETON: Open Payments
NPI 1154864742 · GREENVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,457 in 44 payments from 14 companies in 2025. Trend: 2023 $1,208 · 2024 $1,360 · 2025 $1,457
Food & beverage: $1,457
| Company | Payments | Amount |
|---|---|---|
| Jenavalve Technology, Inc. | 1 | $257 |
| Novartis Pharmaceuticals Corporation | 13 | $238 |
| PFIZER INC. | 8 | $199 |
| Amgen Inc. | 10 | $174 |
| Itamar Medical Inc | 1 | $124 |
| Recor Medical Inc | 1 | $117 |
| AstraZeneca Pharmaceuticals LP | 1 | $111 |
| ABIOMED | 1 | $54 |
| Novo Nordisk Inc | 2 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
Products named: LEQVIO, ELIQUIS, REPATHA, WatchPATONE, Paradise Ultrasound Renal Denervation System, Wegovy, JARDIANCE, Attruby.
Industry payments across TX — which companies pay providers there.
